However, very high doses should be avoided unless recommended by a healthcare provider
5-Amino-1MQ was developed as a pharmacological tool to inhibit NNMT activity, and preclinical studies have demonstrated that oral administration of 5-Amino-1MQ to obese rodents produces dose-dependent reductions in body weight and fat mass, improvements in glucose metabolism and insulin sensitivity, and increases in energy expenditure - remarkably, these effects occur without changes in food intake, indicating that 5-Amino-1MQ works through metabolic enhancement and increased caloric burn rather than appetite suppression
Expired water carries risk
For TB-500, the status is similar (Investigational New Drug in the US) with very limited human data
By addressing underlying health factors, we help patients achieve long-term success in their weight loss journey
However, always tell us what medications you're currently taking so we can make sure there are no interactions
